Senior Scientist
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
• Credentialed pathways/targets responsible for kidney injury/inflammation/fibrosis in acquired and inherited kidney diseases using RNA technologies integrated with genomic approach. • Established and managed collaborations with internal/external research teams to define therapeutic strategies for rare inherited genetic disorders leading to kidney injury. • Developed cell-based assays to support lead validation and optimization; developed in-vitro and ex-vivo models to screen tool compounds against fibrotic/inflammatory response and cellular injury. • Prepared study protocols and generated proof-of-concept data in established and novel in-vivo models to assess preclinical efficacy of lead candidates in preventing kidney fibrosis in chronic kidney disease. • Employed immunoassays (SDS-PAGE, ELISA, luminex), molecular/cellular assay (QRT-PCR, TLDA, RNAi, and cell proliferation/differentiation/cytotoxicity), exosome, and Flow Cytometry • Analyzed RNA data to identify pharmacodynamic biomarkers associated with mechanism of action to support clinical development of drug candidates for metabolic and kidney diseases. • Supervised research associates including hiring, training, and performance reviews. Explored cellular stress/oxidative stress/mitochondrial dysfunction in kidney cell damage and apoptosis; developed cellular assays to evaluate biological targets responsible for damage and apoptosis. • Used RNAi-based gene silencing, in vivo siRNA Delivery, and genetic and developed novel mouse models to explore the role of kidney disease, fibrosis and metabolic diseases. • Identified biological targets and explored therapeutic implications in preclinical mouse models of diabetes and focal segmental glomerulosclerosis to improve renal function and inflammation. • Developed fluorescence-based cellular and imaging assays to measure calcium channel activity and cellular stress. • Supervised students and laboratory technicians.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of John Vassiliadis at Blueprint Medicines then you’ve come to the right place.
Wondering if it's john@blueprintmedicines.com, john.vassiliadis@blueprintmedicines.com, vassiliadis@blueprintmedicines.com, or jvassiliadis@blueprintmedicines.com? We have the answers for you.